We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$42.9M
Cap. Flow
+$32.6M
Cap. Flow %
18.19%
Top 10 Hldgs %
60.25%
Holding
43
New
12
Increased
10
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
HNGR
Hanger Inc.
HNGR
+$26M
2
ZBH icon
Zimmer Biomet
ZBH
+$7.83M
3
MODV
ModivCare
MODV
+$5.92M
4
ALBO
Albireo Pharma Inc
ALBO
+$5.33M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$4.24M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$8.93M
2
AGN
Allergan plc
AGN
+$7.4M
3
ATHN
Athenahealth, Inc.
ATHN
+$6.55M
4
CDTX
Cidara Therapeutics
CDTX
+$3.68M
5
MGNX icon
MacroGenics
MGNX
+$3.43M

Sector Composition

Rank Sector Weight
1 Healthcare 98.36%
2 Miscellaneous 1.64%
3 Industrials 0%
4 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
26
DELISTED
Strongbridge Biopharma plc.
SBBP
$2.06M 1.15%
+423,846
New +$2.17M
CDTX
27
DELISTED
Cidara Therapeutics
CDTX
$1.43M 0.8%
16,245
-41,690
-72% -$3.68M
NVLN
28
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.31M 0.73%
444,068
+249,405
+128% +$883K
KZR
29
DELISTED
Kezar Life Sciences
KZR
$1.12M 0.62%
5,233
+1,064
+26% +$186K
TPST icon
30
Tempest Therapeutics
TPST
$17.5M
$1.12M 0.62%
+523
New +$1.26M
MGTX icon
31
MeiraGTx Holdings
MGTX
$1.33B
$527K 0.29%
+38,746
New +$419K
NGNE icon
32
Neurogene
NGNE
$732M
$166K 0.09%
2,833
-17,212
-86% -$1.02M
CLLS
33
Cellectis
CLLS
$342M
– –
-19,388
Closed -$548K
ESPR
34
DELISTED
Esperion Therapeutics
ESPR
– –
-48,800
Closed -$1.91M
SBRA icon
35
Sabra Healthcare REIT
SBRA
$5.27B
– –
-98,906
Closed -$2.15M
VTRS icon
36
Viatris
VTRS
$18.8B
– –
-80,800
Closed -$2.92M
PRTK
37
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-144,752
Closed -$1.48M
NBRV
38
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
-1,686
Closed -$1.47M
AVEO
39
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-7,010
Closed -$158K
AVEO
40
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-14,907
Closed -$337K
AKAO
41
DELISTED
Achaogen Inc
AKAO
– –
-375,000
Closed -$3.25M
CIVI
42
DELISTED
Civitas Solutions, Inc.
CIVI
– –
-34,649
Closed -$568K
ATHN
43
DELISTED
Athenahealth, Inc.
ATHN
– –
-41,193
Closed -$6.55M
1
2

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q3 2018 Portfolio in Review

As of Q3 2018, Prosight Management held 43 positions worth $179M, up 31% from $136M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Prosight Management deployed $32.6M of net new capital in Q3 2018, opening 12 new positions and adding to 10 existing holdings. Its largest new stake was Hanger Inc.: 1,199,602 shares worth $25M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 94% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Cigna, an estimated $8.93M trimmed.

  • Prosight Management's largest Q3 2018 buy was Hanger Inc.: 1,199,602 shares worth $25M.
  • Prosight Management added most to Arena Pharmaceuticals Inc in Q3 2018, an estimated $4.24M increase.
  • Prosight Management's biggest Q3 2018 reduction was Cigna, cutting an estimated $8.93M.
  • Prosight Management fully exited Athenahealth, Inc. in Q3 2018, selling an estimated $6.55M.
  • Prosight Management's ten largest holdings make up 60% of its $179M portfolio in Q3 2018.
  • Prosight Management opened 12 new positions and closed 11 in Q3 2018.
  • Prosight Management's portfolio value rose 31% quarter-over-quarter to $179M.

Based on Prosight Management's 13F filing for Q3 2018, filed 15 Nov 2018.